Galderma announced today that the Swedish Medical Products Agency (Läkemedelsverket) issued key manufacturing license updates for new biologics capabilities at its center of excellence. This will enable Galderma to pursue its ambitious growth and innovation roadmap, and increase its autonomy in bringing new blockbuster platforms to market in dermatology. Read more: https://lnkd.in/eC-XgyCU #AdvancingDermatology
Obrigada pelos excelentes products. Contribui para nossa saúde! Galderma
Exciting times!
Amazing news!!!
Congratulations!
Congratulations Adrian!
Principal Scientist with a passion for People and Processes - Galderma
2wAmazing news and well done to all that were involved in the journey!